Multicenter clinical study showcases how Tenzing® technology is improving neurovascular intervention outcomes SAN MATEO, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) — Route 92 Medical, a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced compelling results from a multicenter clinical study1 on the […]
Neuro
RapidAI Receives FDA Clearance of AI Module for Detection of Hemispheric Subdural Hematomas
SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, the global leader in developing Artificial Intelligence (AI) and technology workflow solutions to combat life-threatening neurovascular, trauma, cardiac and vascular conditions, today announced it has received FDA clearance for Rapid SDH, its AI-powered module for the detection and notification of suspected hemispheric acute and chronic subdural hematoma. Together with Rapid ICH and Rapid Hyperdensity, the three modules comprise RapidAI’s unique and
Perfuze® Announces First Stroke Patient Enrolled in the MARRS Pivotal Clinical Trial for the Millipede System
GALWAY, Ireland–(BUSINESS WIRE)–Perfuze, a private medical device company dedicated to developing pioneering technology to treat acute ischemic stroke, announced commencement of enrollment in its pivotal MARRS (Millipede AspiRation for Revascularization in Stroke) clinical study. MARRS is a multi-center trial to evaluate the performance of the Millipede System. The first patient was enrolled at Stony Brook University Hospital in Stony Brook, NY. “I am delighted to begin enrollment in the MARR
Texas County Memorial Hospital Goes Live with RapidAI to Enhance Neurovascular Decision Making and Rural Stroke Care
SAN MATEO, Calif. & HOUSTON, Mo.–(BUSINESS WIRE)–RapidAI, a global leader in developing Artificial Intelligence (AI) and technology workflow solutions to combat life-threatening neurovascular, cardiac and vascular diseases, is pleased to announce Texas County Memorial Hospital’s (TCMH) implementation of RapidAI’s core stroke imaging and workflow products – including Rapid ICH, LVO, CTA and CTP – as part of its ongoing commitment to enhancing the quality of stroke care for patients in rural so
Imperative Care Announces Positive New Data Demonstrating the Use of Zoom Aspiration Catheters is Associated with Lower Procedural Cost in Patients with Acute Ischemic Stroke
CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, a medical technology company developing connected innovations to elevate care for people affected by stroke and other ischemic diseases, today announced the publication of clinical data in Interventional Neuroradiology (INR) of the Zoom Aspiration Catheters in patients with large and medium vessel occlusions. Data from the independent study […]
Anaconda Biomed Announces Additional Granted Patents for its Innovative Thrombectomy Device for Ischemic Stroke Treatment
BARCELONA–(BUSINESS WIRE)–Anaconda Biomed S.L., a medical technology company developing next-generation thrombectomy systems, has announced that the European Patent Office has granted the company a European patent for “A Device and a Thrombectomy Apparatus for Extraction of Thrombus from a Blood Vessel,” published as Patent No. EP3866708 B1 on September 27, […]
Philips and World Stroke Organization partner to improve access to high-quality stroke care
October 10, 2023 Two-year partnership focused on advocacy, education, and raising awareness of stroke as a global healthcare challenge Philips’ leadership in the rapid end-to-end treatment of stroke helping to improve patient outcomes and increase the efficiency of treatment Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a […]
Hyperfine, Inc. Receives FDA Clearance for Updated AI-powered Software with Improved Image Quality for All Swoop® System Sequences
GUILFORD, Conn.–(BUSINESS WIRE)–Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared portable magnetic resonance brain imaging system—the Swoop® system—today announced FDA clearance of updated software. Built on a robust AI foundation, the latest software brings image quality enhancements to the […]
Nanoflex Robotics Secures CHF 2.9M from Swiss Innovation Agency
ZURICH, Switzerland, Oct. 09, 2023 (GLOBE NEWSWIRE) — Nanoflex Robotics AG, a remote robotic surgical company based in Switzerland, announced it has received a second grant from Innosuisse, Switzerland’s Innovation Agency this year. The receipt of the second grant brings Nanoflex Robotics’ total non-dilutive grant funding received from Innosuisse this […]
CONTEGO MEDICAL ANNOUNCES START OF ENROLLMENT IN PERFORMANCE III DIRECT TRANSCAROTID ACCESS STENTING TRIAL
RALEIGH, N.C., Oct. 6, 2023 /PRNewswire/ — Contego Medical Inc., a company dedicated to improving patient outcomes and procedural efficiency in the treatment of carotid and peripheral vascular disease, today announced enrollment of the first patient in the PERFORMANCE III Trial. PERFORMANCE III is a prospective, multicenter trial aimed at further evaluating […]
Recent
Supira Medical Announces FDA Approval for SUPPORT II Pivotal Trial, Advances in Cardiogenic Shock, and Appointment of D. Keith Grossman to Board of Directors
Rapid Medical™ Announces FDA Clearance of TIGERTRIEVER™ 25 and First Clinical Cases
ACHIEVE-4, the longest Phase 3 study of Lilly’s Foundayo (orforglipron) to date, reaffirmed its cardiovascular and overall safety profile as well as consistent improvements across key measures of cardiometabolic health
Popular
- No commented posts yet